Clinical trial
A Study of the Alternative Administration of Ixabepilone and Vinflunine
NCT00362830 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00362830 |
|---|---|
| Title | A Study of the Alternative Administration of Ixabepilone and Vinflunine |
| Official title | A Study of the Alternating Administration of Ixabepilone and Vinflunine Every Three Weeks in Patients With Advanced Cancer |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | vinflunine + ixabepilone |
| Enrollment | 60 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Aug 10, 2006 |
| Last update posted | Sep 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: